Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results (Q69341876)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

title

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

cytomegalovirus retinitis

30 September 2019

main subject

1 reference

H L Cantrill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

K Henry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

N H Melroe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

W H Knobloch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

R C Ramsay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

H H Balfour

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 March 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

367-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

Acquired immune deficiency syndrome. Ocular manifestations

30 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Treatment of cytomegalovirus retinopathy with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Alpha-interferon administration in cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Therapy of cytomegalovirus retinitis with transfer factor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Ophthalmoscopic and histologic findings in cytomegalovirus retinitis treated with BW-B759U

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

BW B759U for cytomegalovirus retinitis: intraocular drug penetration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

Latent Herpesviruses of Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932900-9

7 January 2021

10.1016/S0161-6420(89)32900-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2540470%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference